Anti-gp210 and anti-centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate

被引：7
|
作者：
Honda, Akira [1 ]
Ikegami, Tadashi [1 ]
Matsuzaki, Yasushi [1 ]
机构：
[1] Tokyo Med Univ, Ibaraki Med Ctr, Div Gastroenterol & Hepatol, Ami, Ibaraki, Japan
来源：
HEPATOLOGY RESEARCH | 2015年 / 45卷 / 08期
关键词：
PRIMARY BILIARY-CIRRHOSIS; COMBINATION THERAPY; AUTOANTIBODIES;
D O I：
10.1111/hepr.12461
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：827 / 828
页数：2
相关论文
共 41 条
  • [1] Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
    Nakamura, Minoru
    Kondo, Hisayoshi
    Mori, Tsuyoshi
    Komori, Atsumasa
    Matsuyama, Mutstuni
    Ito, Masahiro
    Takii, Yasushi
    Koyabu, Makiko
    Yokoyama, Terufumi
    Migita, Kiyoshi
    Daikoku, Manabu
    Abiru, Seigo
    Yatsuhashi, Hiroshi
    Takezaki, Eiichi
    Masaki, Naohiko
    Sugi, Kazuhiro
    Honda, Koichi
    Adachi, Hiroshi
    Nishi, Hidehiro
    Watanabe, Yukio
    Nakamura, Yoko
    Shimada, Masaaki
    Komatsu, Tatsuji
    Saito, Akira
    Saoshiro, Takeo
    Harada, Hideharu
    Sodeyama, Takeshi
    Hayashi, Shigeki
    Masumoto, Akihide
    Sando, Takehiro
    Yamamoto, Tetsuo
    Sakai, Hironori
    Kobayashi, Masakazu
    Muro, Toyokichi
    Koga, Michiaki
    Shums, Zakera
    Norman, Gary L.
    Ishibashi, Hiromi
    HEPATOLOGY, 2007, 45 (01) : 118 - 127
  • [2] Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
    Nakamura, Minoru
    Kondo, Hisayoshi
    Mori, Tsuyoshi
    Komori, Atsumasa
    Matsuyama, Mutsumi
    Ito, Masahiro
    Daikoku, Manabu
    Yatsuhashi, Hiroshi
    Takezaki, Eiichi
    Masaki, Naohiko
    Sugi, Kazuhiro
    Adachi, Hiroshi
    Sakai, Norihiro
    Watanabe, Yukio
    Saoshiro, Takeo
    Honda, Koichi
    Harada, Hideharu
    Hayashi, Shigeki
    Sando, Takehiro
    Masumoto, Akihide
    Shimada, Masaaki
    Komatsu, Tatsuji
    Shums, Zakera
    Norman, Gary L.
    Ishibashi, Hiromi
    HEPATOLOGY, 2006, 44 (04) : 629A - 629A
  • [3] The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system
    Ding, Dawei
    Jia, Gui
    Cui, Lina
    Liu, Yansheng
    Wang, Xiufang
    Sun, Ruiqing
    Deng, Juan
    Guo, Guanya
    Shang, Yulong
    Han, Ying
    DIGESTIVE AND LIVER DISEASE, 2025, 57 (04) : 861 - 868
  • [4] Anti-gp210 antibody in combination with anti-centromere antibody may identify PBC patients who are at high risk for end-stage hepatic failure
    Nakamura, M
    Takii, Y
    Mori, T
    Komori, A
    Yokoyama, T
    Daikoku, M
    Matsumoto, T
    Yatsuhashi, H
    Ishibashi, H
    Masaki, N
    Adachi, H
    Watanabe, Y
    Nakamura, Y
    Takezaki, E
    Harada, H
    Sando, T
    Kobayashi, M
    Saoshiro, T
    Shimada, M
    Sodeyama, T
    Hayashi, S
    Muro, T
    Sugi, K
    Masumoto, A
    Shums, Z
    Lee, L
    Norman, G
    HEPATOLOGY, 2005, 42 (04) : 463A - 464A
  • [5] Anti-gp210 and anti-Sp100 antibodies in primary biliary cholangitis
    Ben Lamine, Zeineb
    Ben Jazia, Ilhem
    Ben Ahmed, Mariem
    Ben Slama, Ayda
    Baccouche, Azza
    Slama, Foued
    Jemaa, Ali
    Ghedira, Ibtissem
    Mankai, Amani
    ARAB JOURNAL OF GASTROENTEROLOGY, 2021, 22 (04) : 316 - 320
  • [6] Anti-centromere antibodies in patients with systemic lupus erythematosus
    Respaldiza, N.
    Wichmann, I.
    Ocana, C.
    Garcia-Hernandez, F. J.
    Castillo, M. J.
    Magarino, M. I.
    Magarino, R.
    Torres, A.
    Sanchez-Roman, J.
    Nunez-Roldan, A.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (04) : 290 - 294
  • [7] POSITIVE ANTI-GP210 ANTIBODIES IS A RISK FACTOR FOR POOR BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
    Nakamura, M.
    Ito, M.
    Yamamoto, K.
    Zeniya, M.
    Ohira, H.
    Hashimoto, E.
    Honda, M.
    Kaneko, S.
    Ueno, Y.
    Kikuchi, K.
    Onji, S.
    Shimoda, S.
    Takikawa, H.
    Tanaka, A.
    Komori, A.
    Yatsuhashi, H.
    Kondo, H.
    Harada, K.
    Onishi, S.
    Tsubouchi, H.
    Nakanuma, Y.
    Ishibashi, H.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S514 - S515
  • [8] Kinetics of anti-gp210 antibodies in primary biliary cirrhosis patients with ursodesoxycholic acid therapy
    Boissan, M
    Ballot, E
    Johanet, C
    AUTOANTIGENS AND AUTOANTIBODIES: DIAGNOSTIC TOOLS AND CLUES TO UNDERSTANDING AUTOIMMUNITY, 2000, 1 : 507 - 508
  • [9] Diagnostic Value of Anti-Mitochondrial Antibodies (AMA), Anti-M2, Anti-sp100, and Anti-gp210 in Primary Biliary Cholangitis (PBC)
    Yang, Jane
    Aikins, Ato O.
    Punzalan, Rubio
    Alfego, David
    Chun, Kelly
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S55 - S55
  • [10] SHOULD ALL PATIENTS WITH ANTI-CENTROMERE ANTIBODIES BE REFERRED FOR A RHEUMATOLOGY ASSESSMENT?
    Alkoky, Hoda
    Lazarus, Mark
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1395 - 1395
12345